CD4 and tuberculosis: The intersecting SARS-CoV-2, HIV, and TB epidemics pose additional concerns, particularly as T cell immunity and SARS-CoV-2–specific CD4+ T cells are reduced and display lower polyfunctional capacity in the setting of co-infection [162].